File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0003-9969(94)90026-4
- Scopus: eid_2-s2.0-0028527855
- PMID: 7741664
- WOS: WOS:A1994PQ16800015
- Find via

Supplementary
- Citations:
- Appears in Collections:
Article: The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin
| Title | The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin |
|---|---|
| Authors | |
| Keywords | antifungal agents Candida lactoferrin |
| Issue Date | 1994 |
| Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/archoralbio |
| Citation | Archives Of Oral Biology, 1994, v. 39 n. 10, p. 921-923 How to Cite? |
| Abstract | The effect of subminimal inhibitory concentrations (MICs) of nystatin, amphotericin B, clotrimazole, miconazole and 5-fluorocytosine on the in vitro susceptibility of Candida albicans to physiological concentrations of apo-lactoferrin was investigated. Pre-exposure of C. albicans in 1:4 and 1:16 MICs of the antifungals resulted in an increased resistance to apo-lactoferrin-mediated cell death. Preincubation of Candida in tunicamycin (an agent that inhibits the synthesis of yeast cell-wall mannoproteins) and subsequent exposure to apo-lactoferrin enhanced the antifungal activity, whilst addition of ergosterol (a yeast cell-wall component) to the assay suspension had no significant effect. These results taken together indicate that apo-lactoferrin, an important component of saliva, interacts with cell-membrane constituents of C. albicans such as mannoproteins, and may modulate the effect of topical antifungal agents commonly prescribed for oral candidoses. |
| Persistent Identifier | http://hdl.handle.net/10722/153901 |
| ISSN | 2023 Impact Factor: 2.2 2023 SCImago Journal Rankings: 0.562 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Nikawa, H | en_US |
| dc.contributor.author | Samaranayake, LP | en_US |
| dc.contributor.author | Tenovuo, J | en_US |
| dc.contributor.author | Hamada, T | en_US |
| dc.date.accessioned | 2012-08-08T08:22:11Z | - |
| dc.date.available | 2012-08-08T08:22:11Z | - |
| dc.date.issued | 1994 | en_US |
| dc.identifier.citation | Archives Of Oral Biology, 1994, v. 39 n. 10, p. 921-923 | en_US |
| dc.identifier.issn | 0003-9969 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10722/153901 | - |
| dc.description.abstract | The effect of subminimal inhibitory concentrations (MICs) of nystatin, amphotericin B, clotrimazole, miconazole and 5-fluorocytosine on the in vitro susceptibility of Candida albicans to physiological concentrations of apo-lactoferrin was investigated. Pre-exposure of C. albicans in 1:4 and 1:16 MICs of the antifungals resulted in an increased resistance to apo-lactoferrin-mediated cell death. Preincubation of Candida in tunicamycin (an agent that inhibits the synthesis of yeast cell-wall mannoproteins) and subsequent exposure to apo-lactoferrin enhanced the antifungal activity, whilst addition of ergosterol (a yeast cell-wall component) to the assay suspension had no significant effect. These results taken together indicate that apo-lactoferrin, an important component of saliva, interacts with cell-membrane constituents of C. albicans such as mannoproteins, and may modulate the effect of topical antifungal agents commonly prescribed for oral candidoses. | en_US |
| dc.language | eng | en_US |
| dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/archoralbio | en_US |
| dc.relation.ispartof | Archives of Oral Biology | en_US |
| dc.subject | antifungal agents | - |
| dc.subject | Candida | - |
| dc.subject | lactoferrin | - |
| dc.subject.mesh | Amphotericin B - Pharmacology | en_US |
| dc.subject.mesh | Antifungal Agents - Pharmacology | en_US |
| dc.subject.mesh | Apoproteins - Pharmacology | en_US |
| dc.subject.mesh | Candida Albicans - Drug Effects | en_US |
| dc.subject.mesh | Cell Death - Drug Effects | en_US |
| dc.subject.mesh | Cell Wall - Chemistry | en_US |
| dc.subject.mesh | Clotrimazole - Pharmacology | en_US |
| dc.subject.mesh | Drug Resistance, Microbial | en_US |
| dc.subject.mesh | Ergosterol - Pharmacology | en_US |
| dc.subject.mesh | Flucytosine - Pharmacology | en_US |
| dc.subject.mesh | Lactoferrin - Pharmacology | en_US |
| dc.subject.mesh | Membrane Glycoproteins - Antagonists & Inhibitors | en_US |
| dc.subject.mesh | Miconazole - Pharmacology | en_US |
| dc.subject.mesh | Nystatin - Pharmacology | en_US |
| dc.subject.mesh | Tunicamycin - Pharmacology | en_US |
| dc.title | The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin | en_US |
| dc.type | Article | en_US |
| dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_US |
| dc.identifier.authority | Samaranayake, LP=rp00023 | en_US |
| dc.description.nature | link_to_subscribed_fulltext | en_US |
| dc.identifier.doi | 10.1016/0003-9969(94)90026-4 | en_US |
| dc.identifier.pmid | 7741664 | en_US |
| dc.identifier.scopus | eid_2-s2.0-0028527855 | en_US |
| dc.identifier.hkuros | 3543 | - |
| dc.identifier.volume | 39 | en_US |
| dc.identifier.issue | 10 | en_US |
| dc.identifier.spage | 921 | en_US |
| dc.identifier.epage | 923 | en_US |
| dc.identifier.isi | WOS:A1994PQ16800015 | - |
| dc.publisher.place | United Kingdom | en_US |
| dc.identifier.scopusauthorid | Nikawa, H=7006724162 | en_US |
| dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_US |
| dc.identifier.scopusauthorid | Tenovuo, J=7005439975 | en_US |
| dc.identifier.scopusauthorid | Hamada, T=7401759268 | en_US |
| dc.identifier.issnl | 0003-9969 | - |
